GENESIS Pharma
Tassos Zissis is a seasoned finance professional with extensive experience in accounting and compliance. Currently serving as Group Accounting Manager at Genesis Pharma S.A. since May 2007, Tassos has developed a strong expertise in financial management. Prior to this role, Tassos spent nearly 18 years at PricewaterhouseCoopers as a Senior Manager in the Global Compliance Services – Tax and Legal Services department. Tassos holds a degree from the Technological Educational Institute of Thessaly, where education was completed from 1986 to 1989.
This person is not in any offices
GENESIS Pharma
GENESIS Pharma is a regional biopharma company focused on the commercialization of innovative pharmaceutical products for severe and rare diseases in Central and Eastern Europe. Founded in 1997 in Greece, GENESIS Pharma S.A. was among the first pharmaceutical companies in Europe to specialize in the marketing, sales and distribution of biopharmaceutical products. In 1999, business activities were expanded in Cyprus through the creation of GENESIS Pharma (Cyprus) Ltd, and later on, in markets of Southeast Europe. GENESIS Pharma (Cyprus) Ltd, an affiliate (sister) company, now operates in Central and Eastern Europe, through its subsidiaries in Bulgaria, Croatia, Czech Republic, Hungary, Poland, Romania, Slovakia, Slovenia (EU) as well as North Macedonia and Serbia (Non-EU). GENESIS Pharma maintains a strong portfolio in therapeutic areas with high unmet medical need through long standing strategic alliances with leading international pharma companies committed to cutting-edge R&D as well as biopharma companies with disruptive innovations for the development of targeted, specialized treatments for orphan diseases. For more information, please visit www.genesispharmagroup.com and www.genesispharma.com